Article Versions Notes

Tlegenova Z, Balmagambetova S, Zholdin B, Kurmanalina G, Talipova I, Koyshybaev A, Sultanbekova G, Baspayeva M, Madinova S, Kubenova K, et al. Role of Clinical Risk Factors and B-Type Natriuretic Peptide in Assessing the Risk of Asymptomatic Cardiotoxicity in Breast Cancer Patients in Kazakhstan. Diagnostics. 2023; 13(23):3557. https://doi.org/10.3390/diagnostics13233557

Tlegenova, Zhenisgul, Saule Balmagambetova, Bekbolat Zholdin, Gulnara Kurmanalina, Iliada Talipova, Arip Koyshybaev, Gulmira Sultanbekova, Mira Baspayeva, Saule Madinova, Kulparshan Kubenova, and et al. 2023. "Role of Clinical Risk Factors and B-Type Natriuretic Peptide in Assessing the Risk of Asymptomatic Cardiotoxicity in Breast Cancer Patients in Kazakhstan" Diagnostics 13, no. 23: 3557. https://doi.org/10.3390/diagnostics13233557

Tlegenova, Z., Balmagambetova, S., Zholdin, B., Kurmanalina, G., Talipova, I., Koyshybaev, A., Sultanbekova, G., Baspayeva, M., Madinova, S., Kubenova, K., Amanova, A., & Tamadon, A. (2023). Role of Clinical Risk Factors and B-Type Natriuretic Peptide in Assessing the Risk of Asymptomatic Cardiotoxicity in Breast Cancer Patients in Kazakhstan. Diagnostics, 13(23), 3557. https://doi.org/10.3390/diagnostics13233557